Recombinant human EGF (rhEGF) and the synthetic analog sh-Oligopeptide-1 are now widely formulated into cosmeceutical serums
FDA-approved tirzepatide and injectable semaglutide products were on the shortage list
In line with these findings, deletion of GLP-1Rs in paired-like homeobox 2b (PHOX2B)-expressing neurons, which mark all vagal sensory afferents, minimally affects the acute appetite suppressing effects of exendin-4 and only partially prevents the weight loss caused by chronic treatment with the GLP-1R agonist dulaglutide [35]
In practice, this often includes women with obesity (e.g., BMI 30 kg/m 2 )or those close to this threshold with clinically meaningful IR and/or metabolic comorbidities such as MASLD or impaired glucose tolerancewho have a defined plan for conception or ART within the next year
Working in obesity medicine has opened my eyes to the stigma surrounding this chronic disease
Whether your goal is brighter skin, a stronger immune system, or full-body detox, choosing a trusted provider ensures the safest path to success